Telix Pharmaceuticals Limited American Depositary Shares is a depositary share security representing ordinary shares of Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company focused on therapeutic and diagnostic radiopharmaceuticals. The company develops and commercializes products across oncology and precision medicine, with an emphasis on targeted radioactive medicines used in cancer care and medical imaging. Its current business spans therapeutics, precision medicine, and manufacturing solutions, supporting the discovery, production, and delivery of radiopharmaceutical products and related technologies. Telix Pharmaceuticals Limited also works with healthcare providers, hospitals, and research partners in markets that rely on specialized nuclear medicine and molecular imaging tools. As an American Depositary Share, it provides U.S. investors with a U.S.-traded form of exposure to the company’s ordinary shares while the underlying business remains centered on its biopharmaceutical operations.
Australia
Telix Pharmaceuticals Limited (NASDAQ:TLX) agreed on September 21 to acquire ITM Isotope Technologies Munich SE. The deal is worth up to $2.35 billion. Telix will pay $1.65 billion upfront, before cash and debt. A further $700 million follows if ITM’s lead drug wins approval and hits sales targets. Telix is paying mostly in its own […]
Telix Pharmaceuticals acquires ITM Isotope for $1.65B to create a radiopharmaceutical leader. Here is what investors need to know.
About This EventTelix Pharmaceuticals Limited (Nasdaq:TLX), a commercial-stage global radiopharmaceutical company, advancing precision diagnostics and targeted radionuclide therapies to improve outcomes for people with cancer, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Dr. Christian Behrenbruch, Managing Director & Group Chief Executive Officer rings the Closing Bell.
Telix Pharmaceuticals to buy Germany’s ITM Isotope in a $1.65B deal, boosting radiopharma scale and 2026 revenue outlook—read the details now.
Investors talking about TLX also mention
What share of all ETF conversation is about TLX?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% 0 | 0.01% +0 | 0% +0 |
Of the messages about TLX that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 93.33% +18.33 | 95.31% -4.69 | 87.92% +27.34 | ||
| Bearish | 0% | 6.67% -18.33 | 4.69% new | 12.08% -27.34 |
Of the messages about TLX that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | 100% | 100% | 97.78% | 89.9% | ||
| Macro | 0% | 0% | 2.22% | 10.1% |
Of the messages about TLX, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 63.64% | 56.76% | 40.96% | ||
| Newcomers | 0% | 36.36% | 43.24% | 59.04% |